Global Regenerative Medicine Market to Reach $39.33 Bn by 2023 at 32.2% CAGR, Says Allied Market Research

Rise in adoption of stem cell technology, rise in application of nanotechnology, increased prevalence of chronic diseases and trauma emergencies, and increasing technological advancements in medical equipment technology are expected to propel the growth of the global regenerative medicine market.

Portland, OR, March 25, 2019 (GLOBE NEWSWIRE) -- Allied Market Research recently published a report, titled, “Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017–2023”. According to the report, the global regenerative medicine market accounted for $7.37 billion in 2017 and is projected to garner $39.33 billion by 2023, registering a CAGR of 32.2% during the period 2017–2023.

Increased adoption of stem cell technology, emerging application of nanotechnology, rise in prevalence of chronic diseases and trauma emergencies, and advancements in medical equipment technology have boosted growth of the global regenerative medicine market. However, high cost of treatment associated with regenerative medicine hampers the market growth. On the contrary, increase in potential in emerging economies and growing need of regenerative medicine in organ transplantation are expected to create lucrative opportunities in the near future.

Request Report Sample https://www.alliedmarketresearch.com/request-sample/391

The global regenerative medicine market is divided on the basis of product type, material, application, and geography. Based on product type, the market is segmented into cell therapy, gene therapy, tissue engineering, and small molecule & biologic. The cell therapy segment held the largest share in 2017, contributing nearly two-thirds of the total market, owing to its efficiency to restore the lost function of tissues and organs. However, the small molecules & biologics segment is expected to manifest CAGR of 33.3% during the forecast period, owing to its potential to stimulate dormant or endogenous cells to regain their regenerative properties.

On the basis of material, the market is divided into synthetic material, biologically derived material, genetically engineered material, and pharmaceutical. The synthetic material segment is expected to portray the fastest CAGR of 34.6% during the forecast period. This is attributed to the growing demand for these materials as it allows to obtain scaffolds with more reproducible and predictable physical behavior. However, the biologically derived material segment dominated the market in terms of revenue, contributing nearly two-thirds of the total market, owing to the advantages of using these materials such as good biocompatibility and biodegradability.

The North America region held the largest share in 2017, contributing about half of the total market, owing to presence of major players and rapid advancements in technology, and high investments in the stem cell and oncology research. However, the Asia-Pacific region is expected to register the fastest CAGR of 38.6% during the forecast period, owing to rise in awareness regarding benefits of regenerative medicine, and presence of large patient population.

Purchase Inquiry https://www.alliedmarketresearch.com/purchase-enquiry/391

The report includes study of the major companies that are active in the market, including Stryker Corporation, Medtronic Plc., U.S. Stem Cell, Inc. (Bioheart, Inc.), Organogenesis, Inc. (Advanced Biohealing), Acelity Holdings, Inc., CryoLife, Inc., Zimmer Biomet Holdings, Inc., Athersys, Inc., Integra Lifesciences Holdings Corporation, and Isto Biologics (Isto Biologics Medical Systems, Inc.).

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
                    David Correa
                    5933 NE Win Sivers Drive
                    #205, Portland, OR 97220
                    United States
                    Toll Free (USA/Canada): 
                    +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
                    UK: +44-845-528-1300
                    Hong Kong: +852-301-84916
                    India (Pune): +91-20-66346060
                    Fax: +1-855-550-5975
                    help@alliedmarketresearch.com 
                    Web: https://www.alliedmarketresearch.com